Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.02 CHF | -0.53% | -2.03% | +4.83% |
Apr. 08 | Citi recommends Wacker Chemie and Evonik - BASF, Lanxess 'Neutral' | DP |
Apr. 03 | Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft... |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.83% | 4.71B | B+ | ||
+11.09% | 63.12B | A- | ||
+12.69% | 40.45B | B+ | ||
+17.66% | 26.45B | A- | ||
+4.77% | 18.31B | C+ | ||
-1.09% | 17.34B | B+ | ||
-21.87% | 16.71B | A- | ||
+0.28% | 15.55B | B+ | ||
-21.99% | 13.55B | C+ | ||
+31.94% | 12.94B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLN Stock
- Ratings Clariant AG